nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.0259	0.0648	CcSEcCtD
Dasatinib—Localised oedema—Hydrochlorothiazide—nephrolithiasis	0.0259	0.0648	CcSEcCtD
Dasatinib—FMO3—urine—nephrolithiasis	0.0188	0.0462	CbGeAlD
Dasatinib—EPHB1—renal system—nephrolithiasis	0.0115	0.0282	CbGeAlD
Dasatinib—EPHB1—kidney—nephrolithiasis	0.0111	0.0273	CbGeAlD
Dasatinib—SIK2—renal system—nephrolithiasis	0.0101	0.0249	CbGeAlD
Dasatinib—FRK—renal system—nephrolithiasis	0.00986	0.0243	CbGeAlD
Dasatinib—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00949	0.0238	CcSEcCtD
Dasatinib—SRMS—renal system—nephrolithiasis	0.0092	0.0227	CbGeAlD
Dasatinib—PTK6—renal system—nephrolithiasis	0.00902	0.0222	CbGeAlD
Dasatinib—SRMS—kidney—nephrolithiasis	0.0089	0.0219	CbGeAlD
Dasatinib—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00882	0.0221	CcSEcCtD
Dasatinib—STAT5B—renal system—nephrolithiasis	0.00853	0.021	CbGeAlD
Dasatinib—SIK3—nephron tubule—nephrolithiasis	0.00843	0.0208	CbGeAlD
Dasatinib—STAT5B—kidney—nephrolithiasis	0.00824	0.0203	CbGeAlD
Dasatinib—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0185	CcSEcCtD
Dasatinib—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00728	0.0182	CcSEcCtD
Dasatinib—SIK3—cortex of kidney—nephrolithiasis	0.00722	0.0178	CbGeAlD
Dasatinib—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00704	0.0176	CcSEcCtD
Dasatinib—TESK1—nephron tubule—nephrolithiasis	0.00693	0.0171	CbGeAlD
Dasatinib—CYP1A2—urine—nephrolithiasis	0.00678	0.0167	CbGeAlD
Dasatinib—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00665	0.0167	CcSEcCtD
Dasatinib—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00661	0.0166	CcSEcCtD
Dasatinib—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00653	0.0164	CcSEcCtD
Dasatinib—CSK—nephron tubule—nephrolithiasis	0.00635	0.0156	CbGeAlD
Dasatinib—TESK1—renal system—nephrolithiasis	0.0063	0.0155	CbGeAlD
Dasatinib—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00597	0.015	CcSEcCtD
Dasatinib—TESK1—cortex of kidney—nephrolithiasis	0.00593	0.0146	CbGeAlD
Dasatinib—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0148	CcSEcCtD
Dasatinib—RIPK2—nephron tubule—nephrolithiasis	0.00589	0.0145	CbGeAlD
Dasatinib—STK36—cortex of kidney—nephrolithiasis	0.00584	0.0144	CbGeAlD
Dasatinib—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00581	0.0146	CcSEcCtD
Dasatinib—CSK—renal system—nephrolithiasis	0.00577	0.0142	CbGeAlD
Dasatinib—SIK1—nephron tubule—nephrolithiasis	0.00576	0.0142	CbGeAlD
Dasatinib—LIMK2—cortex of kidney—nephrolithiasis	0.00564	0.0139	CbGeAlD
Dasatinib—ERBB3—nephron tubule—nephrolithiasis	0.00564	0.0139	CbGeAlD
Dasatinib—MAP3K2—nephron tubule—nephrolithiasis	0.00559	0.0138	CbGeAlD
Dasatinib—CSK—kidney—nephrolithiasis	0.00558	0.0137	CbGeAlD
Dasatinib—CSK—cortex of kidney—nephrolithiasis	0.00544	0.0134	CbGeAlD
Dasatinib—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0135	CcSEcCtD
Dasatinib—SIK1—renal system—nephrolithiasis	0.00523	0.0129	CbGeAlD
Dasatinib—ERBB3—renal system—nephrolithiasis	0.00513	0.0126	CbGeAlD
Dasatinib—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00511	0.0128	CcSEcCtD
Dasatinib—SIK1—kidney—nephrolithiasis	0.00506	0.0125	CbGeAlD
Dasatinib—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.005	0.0125	CcSEcCtD
Dasatinib—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.005	0.0125	CcSEcCtD
Dasatinib—EPHB4—nephron tubule—nephrolithiasis	0.00498	0.0123	CbGeAlD
Dasatinib—ERBB3—kidney—nephrolithiasis	0.00496	0.0122	CbGeAlD
Dasatinib—SIK1—cortex of kidney—nephrolithiasis	0.00493	0.0121	CbGeAlD
Dasatinib—CYP3A4—urine—nephrolithiasis	0.0049	0.0121	CbGeAlD
Dasatinib—EPHA2—nephron tubule—nephrolithiasis	0.00489	0.012	CbGeAlD
Dasatinib—FYN—nephron tubule—nephrolithiasis	0.00488	0.012	CbGeAlD
Dasatinib—MAPK14—renal system—nephrolithiasis	0.00478	0.0118	CbGeAlD
Dasatinib—MAP3K3—nephron tubule—nephrolithiasis	0.00477	0.0117	CbGeAlD
Dasatinib—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00474	0.0119	CcSEcCtD
Dasatinib—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0047	0.0118	CcSEcCtD
Dasatinib—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00467	0.0117	CcSEcCtD
Dasatinib—MAPK14—kidney—nephrolithiasis	0.00462	0.0114	CbGeAlD
Dasatinib—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00458	0.0115	CcSEcCtD
Dasatinib—EPHB4—renal system—nephrolithiasis	0.00453	0.0111	CbGeAlD
Dasatinib—JAK2—renal system—nephrolithiasis	0.0045	0.0111	CbGeAlD
Dasatinib—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00444	0.0111	CcSEcCtD
Dasatinib—FYN—renal system—nephrolithiasis	0.00443	0.0109	CbGeAlD
Dasatinib—YES1—nephron tubule—nephrolithiasis	0.0044	0.0108	CbGeAlD
Dasatinib—EPHB4—kidney—nephrolithiasis	0.00438	0.0108	CbGeAlD
Dasatinib—JAK2—kidney—nephrolithiasis	0.00435	0.0107	CbGeAlD
Dasatinib—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00435	0.0109	CcSEcCtD
Dasatinib—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00431	0.0108	CcSEcCtD
Dasatinib—FYN—kidney—nephrolithiasis	0.00429	0.0106	CbGeAlD
Dasatinib—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00428	0.0107	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00427	0.0107	CcSEcCtD
Dasatinib—EPHB4—cortex of kidney—nephrolithiasis	0.00426	0.0105	CbGeAlD
Dasatinib—JAK2—cortex of kidney—nephrolithiasis	0.00423	0.0104	CbGeAlD
Dasatinib—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0105	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0105	CcSEcCtD
Dasatinib—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0105	CcSEcCtD
Dasatinib—FYN—cortex of kidney—nephrolithiasis	0.00417	0.0103	CbGeAlD
Dasatinib—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00412	0.0103	CcSEcCtD
Dasatinib—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0041	0.0103	CcSEcCtD
Dasatinib—MAP4K5—cortex of kidney—nephrolithiasis	0.00408	0.01	CbGeAlD
Dasatinib—MAP3K3—cortex of kidney—nephrolithiasis	0.00408	0.01	CbGeAlD
Dasatinib—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00402	0.0101	CcSEcCtD
Dasatinib—YES1—renal system—nephrolithiasis	0.004	0.00985	CbGeAlD
Dasatinib—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00399	0.01	CcSEcCtD
Dasatinib—PDGFRA—renal system—nephrolithiasis	0.00393	0.00967	CbGeAlD
Dasatinib—EPHB6—cortex of kidney—nephrolithiasis	0.0039	0.0096	CbGeAlD
Dasatinib—YES1—kidney—nephrolithiasis	0.00387	0.00953	CbGeAlD
Dasatinib—SRC—renal system—nephrolithiasis	0.00385	0.00948	CbGeAlD
Dasatinib—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00383	0.0096	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00955	CcSEcCtD
Dasatinib—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00949	CcSEcCtD
Dasatinib—YES1—cortex of kidney—nephrolithiasis	0.00377	0.00928	CbGeAlD
Dasatinib—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00938	CcSEcCtD
Dasatinib—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00935	CcSEcCtD
Dasatinib—SRC—kidney—nephrolithiasis	0.00372	0.00916	CbGeAlD
Dasatinib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00921	CcSEcCtD
Dasatinib—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00903	CcSEcCtD
Dasatinib—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00359	0.009	CcSEcCtD
Dasatinib—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00898	CcSEcCtD
Dasatinib—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00898	CcSEcCtD
Dasatinib—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00355	0.0089	CcSEcCtD
Dasatinib—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00873	CcSEcCtD
Dasatinib—KIT—nephron tubule—nephrolithiasis	0.00345	0.0085	CbGeAlD
Dasatinib—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00345	0.00864	CcSEcCtD
Dasatinib—MAP2K5—cortex of kidney—nephrolithiasis	0.00333	0.00821	CbGeAlD
Dasatinib—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00822	CcSEcCtD
Dasatinib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0081	CcSEcCtD
Dasatinib—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00792	CcSEcCtD
Dasatinib—KIT—renal system—nephrolithiasis	0.00314	0.00773	CbGeAlD
Dasatinib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00777	CcSEcCtD
Dasatinib—PDGFRB—renal system—nephrolithiasis	0.00306	0.00755	CbGeAlD
Dasatinib—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00767	CcSEcCtD
Dasatinib—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00763	CcSEcCtD
Dasatinib—KIT—kidney—nephrolithiasis	0.00303	0.00747	CbGeAlD
Dasatinib—ABL1—nephron tubule—nephrolithiasis	0.00301	0.0074	CbGeAlD
Dasatinib—PDGFRB—kidney—nephrolithiasis	0.00296	0.0073	CbGeAlD
Dasatinib—KIT—cortex of kidney—nephrolithiasis	0.00295	0.00728	CbGeAlD
Dasatinib—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00734	CcSEcCtD
Dasatinib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00726	CcSEcCtD
Dasatinib—PDGFRB—cortex of kidney—nephrolithiasis	0.00289	0.00711	CbGeAlD
Dasatinib—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00716	CcSEcCtD
Dasatinib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00701	CcSEcCtD
Dasatinib—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00688	CcSEcCtD
Dasatinib—ABL1—renal system—nephrolithiasis	0.00273	0.00673	CbGeAlD
Dasatinib—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00674	CcSEcCtD
Dasatinib—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00671	CcSEcCtD
Dasatinib—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00664	CcSEcCtD
Dasatinib—ABL1—kidney—nephrolithiasis	0.00264	0.0065	CbGeAlD
Dasatinib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00661	CcSEcCtD
Dasatinib—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00645	CcSEcCtD
Dasatinib—ABL1—cortex of kidney—nephrolithiasis	0.00257	0.00633	CbGeAlD
Dasatinib—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00643	CcSEcCtD
Dasatinib—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00642	CcSEcCtD
Dasatinib—CYP1B1—nephron tubule—nephrolithiasis	0.00254	0.00627	CbGeAlD
Dasatinib—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00632	CcSEcCtD
Dasatinib—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00629	CcSEcCtD
Dasatinib—Cough—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00625	CcSEcCtD
Dasatinib—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00609	CcSEcCtD
Dasatinib—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00609	CcSEcCtD
Dasatinib—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00609	CcSEcCtD
Dasatinib—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00607	CcSEcCtD
Dasatinib—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00602	CcSEcCtD
Dasatinib—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00589	CcSEcCtD
Dasatinib—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00584	CcSEcCtD
Dasatinib—CYP1B1—renal system—nephrolithiasis	0.00231	0.0057	CbGeAlD
Dasatinib—Shock—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00575	CcSEcCtD
Dasatinib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00572	CcSEcCtD
Dasatinib—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00227	0.0057	CcSEcCtD
Dasatinib—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00565	CcSEcCtD
Dasatinib—CYP1B1—kidney—nephrolithiasis	0.00224	0.00551	CbGeAlD
Dasatinib—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00557	CcSEcCtD
Dasatinib—CYP1B1—cortex of kidney—nephrolithiasis	0.00218	0.00536	CbGeAlD
Dasatinib—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00546	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00532	CcSEcCtD
Dasatinib—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00528	CcSEcCtD
Dasatinib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00521	CcSEcCtD
Dasatinib—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00519	CcSEcCtD
Dasatinib—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00514	CcSEcCtD
Dasatinib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00508	CcSEcCtD
Dasatinib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00504	CcSEcCtD
Dasatinib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00499	CcSEcCtD
Dasatinib—Pain—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00499	CcSEcCtD
Dasatinib—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00481	CcSEcCtD
Dasatinib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00478	CcSEcCtD
Dasatinib—ABCG2—nephron tubule—nephrolithiasis	0.00189	0.00467	CbGeAlD
Dasatinib—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00464	CcSEcCtD
Dasatinib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00462	CcSEcCtD
Dasatinib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00462	CcSEcCtD
Dasatinib—CYP3A5—nephron tubule—nephrolithiasis	0.00176	0.00433	CbGeAlD
Dasatinib—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0043	CcSEcCtD
Dasatinib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00419	CcSEcCtD
Dasatinib—CYP1A2—renal system—nephrolithiasis	0.00166	0.00408	CbGeAlD
Dasatinib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00413	CcSEcCtD
Dasatinib—CYP1A1—renal system—nephrolithiasis	0.00164	0.00403	CbGeAlD
Dasatinib—CYP3A5—renal system—nephrolithiasis	0.0016	0.00394	CbGeAlD
Dasatinib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00159	0.004	CcSEcCtD
Dasatinib—CYP1A1—kidney—nephrolithiasis	0.00158	0.00389	CbGeAlD
Dasatinib—CYP3A5—kidney—nephrolithiasis	0.00155	0.00381	CbGeAlD
Dasatinib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00386	CcSEcCtD
Dasatinib—CYP3A5—cortex of kidney—nephrolithiasis	0.00151	0.00371	CbGeAlD
Dasatinib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00371	CcSEcCtD
Dasatinib—Rash—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00368	CcSEcCtD
Dasatinib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00368	CcSEcCtD
Dasatinib—Headache—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00366	CcSEcCtD
Dasatinib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00138	0.00347	CcSEcCtD
Dasatinib—CYP3A4—renal system—nephrolithiasis	0.0012	0.00296	CbGeAlD
Dasatinib—CYP3A4—kidney—nephrolithiasis	0.00116	0.00286	CbGeAlD
Dasatinib—ABCB1—nephron tubule—nephrolithiasis	0.000934	0.0023	CbGeAlD
Dasatinib—ABCB1—renal system—nephrolithiasis	0.000849	0.00209	CbGeAlD
Dasatinib—ABCB1—kidney—nephrolithiasis	0.000821	0.00202	CbGeAlD
Dasatinib—ABCB1—cortex of kidney—nephrolithiasis	0.0008	0.00197	CbGeAlD
Dasatinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000578	0.00296	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—SLC7A9—nephrolithiasis	0.000577	0.00296	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—DGKH—nephrolithiasis	0.000577	0.00296	CbGpPWpGaD
Dasatinib—HCK—Focal Adhesion—SPP1—nephrolithiasis	0.000576	0.00295	CbGpPWpGaD
Dasatinib—CSK—Disease—SLC26A1—nephrolithiasis	0.000561	0.00287	CbGpPWpGaD
Dasatinib—SRC—Integrins in angiogenesis—SPP1—nephrolithiasis	0.000549	0.00282	CbGpPWpGaD
Dasatinib—STAT5B—Disease—SLC26A1—nephrolithiasis	0.000543	0.00278	CbGpPWpGaD
Dasatinib—BLK—Focal Adhesion—SPP1—nephrolithiasis	0.000522	0.00268	CbGpPWpGaD
Dasatinib—FGR—Focal Adhesion—SPP1—nephrolithiasis	0.00052	0.00267	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—RGS14—nephrolithiasis	0.000518	0.00266	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000515	0.00264	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—GRHPR—nephrolithiasis	0.000502	0.00258	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—RGS14—nephrolithiasis	0.000502	0.00257	CbGpPWpGaD
Dasatinib—CSK—Disease—ATP6V0A4—nephrolithiasis	0.0005	0.00256	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000497	0.00255	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000497	0.00255	CbGpPWpGaD
Dasatinib—MAP2K5—Focal Adhesion—SPP1—nephrolithiasis	0.000496	0.00254	CbGpPWpGaD
Dasatinib—ERBB3—Signaling by PDGF—SPP1—nephrolithiasis	0.000495	0.00254	CbGpPWpGaD
Dasatinib—MAPK14—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.000488	0.0025	CbGpPWpGaD
Dasatinib—STAT5B—Disease—ATP6V0A4—nephrolithiasis	0.000484	0.00248	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000471	0.00242	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000471	0.00242	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—AGXT—nephrolithiasis	0.000448	0.0023	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—ADCY10—nephrolithiasis	0.00044	0.00226	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—DGKH—nephrolithiasis	0.000431	0.00221	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—SLC7A9—nephrolithiasis	0.000431	0.00221	CbGpPWpGaD
Dasatinib—HCK—Disease—SLC26A1—nephrolithiasis	0.00043	0.00221	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—SLC7A9—nephrolithiasis	0.000429	0.0022	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—DGKH—nephrolithiasis	0.000429	0.0022	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—SLC7A9—nephrolithiasis	0.000424	0.00217	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—DGKH—nephrolithiasis	0.000424	0.00217	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—SLC7A9—nephrolithiasis	0.000408	0.00209	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—DGKH—nephrolithiasis	0.000408	0.00209	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—SLC7A9—nephrolithiasis	0.000403	0.00207	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—DGKH—nephrolithiasis	0.000403	0.00207	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—ADCY10—nephrolithiasis	0.000403	0.00207	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000393	0.00201	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—ADCY10—nephrolithiasis	0.000388	0.00199	CbGpPWpGaD
Dasatinib—KIT—Signaling by PDGF—SPP1—nephrolithiasis	0.000388	0.00199	CbGpPWpGaD
Dasatinib—FYN—BDNF signaling pathway—SPP1—nephrolithiasis	0.000385	0.00197	CbGpPWpGaD
Dasatinib—HCK—Disease—ATP6V0A4—nephrolithiasis	0.000384	0.00197	CbGpPWpGaD
Dasatinib—MAPK14—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.000381	0.00195	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—APRT—nephrolithiasis	0.000381	0.00195	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—SLC26A1—nephrolithiasis	0.000381	0.00195	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000377	0.00193	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—RGS14—nephrolithiasis	0.000375	0.00192	CbGpPWpGaD
Dasatinib—MAPK14—BDNF signaling pathway—SPP1—nephrolithiasis	0.00037	0.0019	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling by PDGF—SPP1—nephrolithiasis	0.000367	0.00188	CbGpPWpGaD
Dasatinib—JAK2—BDNF signaling pathway—SPP1—nephrolithiasis	0.000366	0.00187	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000359	0.00184	CbGpPWpGaD
Dasatinib—ERBB3—Disease—SLC26A1—nephrolithiasis	0.000357	0.00183	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000357	0.00183	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000357	0.00183	CbGpPWpGaD
Dasatinib—PDGFRA—Focal Adhesion—SPP1—nephrolithiasis	0.000355	0.00182	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—SLC7A9—nephrolithiasis	0.000353	0.00181	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—DGKH—nephrolithiasis	0.000353	0.00181	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00035	0.00179	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—DGKH—nephrolithiasis	0.00035	0.00179	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—RGS14—nephrolithiasis	0.000343	0.00176	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—RGS14—nephrolithiasis	0.000342	0.00176	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—ADCY10—nephrolithiasis	0.000341	0.00175	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000339	0.00174	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—DGKH—nephrolithiasis	0.000339	0.00174	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000332	0.0017	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000332	0.0017	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling by PDGF—SPP1—nephrolithiasis	0.000331	0.0017	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—RGS14—nephrolithiasis	0.00033	0.00169	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—PTH—nephrolithiasis	0.000328	0.00168	CbGpPWpGaD
Dasatinib—PDGFRB—Focal Adhesion—SPP1—nephrolithiasis	0.00032	0.00164	CbGpPWpGaD
Dasatinib—FYN—Signaling by PDGF—SPP1—nephrolithiasis	0.000319	0.00164	CbGpPWpGaD
Dasatinib—ERBB3—Disease—ATP6V0A4—nephrolithiasis	0.000318	0.00163	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000313	0.0016	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000313	0.0016	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—SLC7A9—nephrolithiasis	0.000312	0.0016	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—DGKH—nephrolithiasis	0.000312	0.0016	CbGpPWpGaD
Dasatinib—FYN—Focal Adhesion—SPP1—nephrolithiasis	0.000308	0.00158	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—ADCY10—nephrolithiasis	0.000304	0.00156	CbGpPWpGaD
Dasatinib—JAK2—Signaling by PDGF—SPP1—nephrolithiasis	0.000303	0.00155	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000303	0.00155	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000296	0.00152	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000296	0.00152	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—RGS14—nephrolithiasis	0.00029	0.00149	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—ADCY10—nephrolithiasis	0.000288	0.00148	CbGpPWpGaD
Dasatinib—SRC—BDNF signaling pathway—SPP1—nephrolithiasis	0.000283	0.00145	CbGpPWpGaD
Dasatinib—KIT—Disease—SLC26A1—nephrolithiasis	0.00028	0.00144	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000279	0.00143	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—AQP1—nephrolithiasis	0.000271	0.00139	CbGpPWpGaD
Dasatinib—LCK—Signaling by PDGF—SPP1—nephrolithiasis	0.000265	0.00136	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—SLC26A1—nephrolithiasis	0.000265	0.00136	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—ADCY10—nephrolithiasis	0.00026	0.00133	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RGS14—nephrolithiasis	0.000259	0.00133	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000255	0.00131	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000255	0.00131	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000255	0.00131	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—ADCY10—nephrolithiasis	0.000254	0.0013	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000253	0.0013	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—DGKH—nephrolithiasis	0.000253	0.0013	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—CHRM3—nephrolithiasis	0.000253	0.0013	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—ADCY10—nephrolithiasis	0.00025	0.00128	CbGpPWpGaD
Dasatinib—KIT—Disease—ATP6V0A4—nephrolithiasis	0.00025	0.00128	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—CHRM3—nephrolithiasis	0.000245	0.00126	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RGS14—nephrolithiasis	0.000245	0.00126	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—CHRM3—nephrolithiasis	0.000245	0.00126	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—ADCY10—nephrolithiasis	0.000241	0.00124	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—SLC26A1—nephrolithiasis	0.000239	0.00122	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—ADCY10—nephrolithiasis	0.000238	0.00122	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000237	0.00121	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—ATP6V0A4—nephrolithiasis	0.000236	0.00121	CbGpPWpGaD
Dasatinib—SRC—Signaling by PDGF—SPP1—nephrolithiasis	0.000235	0.00121	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—PTH—nephrolithiasis	0.000231	0.00119	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—DGKH—nephrolithiasis	0.000231	0.00119	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000231	0.00119	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—DGKH—nephrolithiasis	0.000231	0.00119	CbGpPWpGaD
Dasatinib—FYN—Disease—SLC26A1—nephrolithiasis	0.00023	0.00118	CbGpPWpGaD
Dasatinib—SRC—Focal Adhesion—SPP1—nephrolithiasis	0.000227	0.00116	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GRHPR—nephrolithiasis	0.000226	0.00116	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—PTH—nephrolithiasis	0.000224	0.00115	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—DGKH—nephrolithiasis	0.000223	0.00114	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000223	0.00114	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RGS14—nephrolithiasis	0.000221	0.00113	CbGpPWpGaD
Dasatinib—JAK2—Disease—SLC26A1—nephrolithiasis	0.000219	0.00112	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RGS14—nephrolithiasis	0.000216	0.00111	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—ATP6V0A4—nephrolithiasis	0.000213	0.00109	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RGS14—nephrolithiasis	0.000213	0.00109	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ADCY10—nephrolithiasis	0.000208	0.00107	CbGpPWpGaD
Dasatinib—FYN—Disease—ATP6V0A4—nephrolithiasis	0.000205	0.00105	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000205	0.00105	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RGS14—nephrolithiasis	0.000205	0.00105	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RGS14—nephrolithiasis	0.000202	0.00104	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AGXT—nephrolithiasis	0.000201	0.00103	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—DGKH—nephrolithiasis	0.000196	0.001	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000196	0.001	CbGpPWpGaD
Dasatinib—JAK2—Disease—ATP6V0A4—nephrolithiasis	0.000195	0.001	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000193	0.00099	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000193	0.00099	CbGpPWpGaD
Dasatinib—LCK—Disease—SLC26A1—nephrolithiasis	0.000192	0.000983	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ADCY10—nephrolithiasis	0.000184	0.000946	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000184	0.000944	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000183	0.000938	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CHRM3—nephrolithiasis	0.000183	0.000938	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00018	0.000921	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00018	0.000921	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RGS14—nephrolithiasis	0.000177	0.000908	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—DGKH—nephrolithiasis	0.000175	0.000896	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000175	0.000896	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—SLC26A1—nephrolithiasis	0.000171	0.000877	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—APRT—nephrolithiasis	0.000171	0.000877	CbGpPWpGaD
Dasatinib—LCK—Disease—ATP6V0A4—nephrolithiasis	0.000171	0.000876	CbGpPWpGaD
Dasatinib—SRC—Disease—SLC26A1—nephrolithiasis	0.00017	0.00087	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—PTH—nephrolithiasis	0.000168	0.000863	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—PTH—nephrolithiasis	0.000167	0.000858	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CHRM3—nephrolithiasis	0.000167	0.000858	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000167	0.000857	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000165	0.000849	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—DGKH—nephrolithiasis	0.000165	0.000849	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000165	0.000845	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CHRM3—nephrolithiasis	0.000161	0.000827	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00016	0.00082	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00016	0.00082	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RGS14—nephrolithiasis	0.000157	0.000804	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—APRT—nephrolithiasis	0.000156	0.000797	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000156	0.000797	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—PTH—nephrolithiasis	0.000153	0.000785	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—PTH—nephrolithiasis	0.000153	0.000784	CbGpPWpGaD
Dasatinib—SRC—Disease—ATP6V0A4—nephrolithiasis	0.000151	0.000776	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—DGKH—nephrolithiasis	0.000149	0.000765	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000149	0.000765	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—PTH—nephrolithiasis	0.000147	0.000756	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000147	0.000754	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—DGKH—nephrolithiasis	0.000146	0.000749	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000146	0.000749	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—DGKH—nephrolithiasis	0.000144	0.000737	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000144	0.000737	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CHRM3—nephrolithiasis	0.000142	0.000726	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000139	0.000712	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000138	0.00071	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DGKH—nephrolithiasis	0.000138	0.00071	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000137	0.0007	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DGKH—nephrolithiasis	0.000137	0.0007	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000131	0.000672	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PTH—nephrolithiasis	0.000129	0.000664	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000128	0.000656	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CHRM3—nephrolithiasis	0.000126	0.000648	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000124	0.000635	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AQP1—nephrolithiasis	0.000122	0.000625	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CHRM3—nephrolithiasis	0.00012	0.000614	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DGKH—nephrolithiasis	0.00012	0.000614	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00012	0.000614	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—SPP1—nephrolithiasis	0.000116	0.000596	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PTH—nephrolithiasis	0.000116	0.000593	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—SPP1—nephrolithiasis	0.000112	0.000577	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000111	0.000571	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000111	0.000571	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000111	0.000569	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000111	0.000568	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CHRM3—nephrolithiasis	0.00011	0.000565	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PTH—nephrolithiasis	0.000109	0.000561	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CHRM3—nephrolithiasis	0.000108	0.000553	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DGKH—nephrolithiasis	0.000106	0.000543	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000106	0.000543	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CHRM3—nephrolithiasis	0.000106	0.000541	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000105	0.00054	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000105	0.00054	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CHRM3—nephrolithiasis	0.000104	0.000533	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.0001	0.000514	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CHRM3—nephrolithiasis	0.0001	0.000513	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AGXT—nephrolithiasis	9.89e-05	0.000507	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CHRM3—nephrolithiasis	9.88e-05	0.000506	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PTH—nephrolithiasis	9.86e-05	0.000506	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PTH—nephrolithiasis	9.65e-05	0.000495	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PTH—nephrolithiasis	9.5e-05	0.000487	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PTH—nephrolithiasis	9.15e-05	0.000469	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PTH—nephrolithiasis	9.03e-05	0.000463	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GRHPR—nephrolithiasis	8.86e-05	0.000454	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CHRM3—nephrolithiasis	8.65e-05	0.000444	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APRT—nephrolithiasis	8.41e-05	0.000431	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC26A1—nephrolithiasis	8.41e-05	0.000431	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—SPP1—nephrolithiasis	8.4e-05	0.000431	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AQP1—nephrolithiasis	7.94e-05	0.000407	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PTH—nephrolithiasis	7.91e-05	0.000406	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AGXT—nephrolithiasis	7.89e-05	0.000405	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—SPP1—nephrolithiasis	7.68e-05	0.000394	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CHRM3—nephrolithiasis	7.66e-05	0.000393	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AQP1—nephrolithiasis	7.5e-05	0.000385	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—SPP1—nephrolithiasis	7.4e-05	0.00038	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CHRM3—nephrolithiasis	7.18e-05	0.000368	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PTH—nephrolithiasis	7e-05	0.000359	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	6.84e-05	0.000351	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CHRM3—nephrolithiasis	6.78e-05	0.000348	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	6.71e-05	0.000344	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APRT—nephrolithiasis	6.71e-05	0.000344	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—SPP1—nephrolithiasis	6.5e-05	0.000333	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AGXT—nephrolithiasis	6.09e-05	0.000312	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AQP1—nephrolithiasis	5.99e-05	0.000307	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—SPP1—nephrolithiasis	5.8e-05	0.000298	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—SPP1—nephrolithiasis	5.49e-05	0.000282	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CHRM3—nephrolithiasis	5.42e-05	0.000278	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	5.18e-05	0.000266	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APRT—nephrolithiasis	5.18e-05	0.000266	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SPP1—nephrolithiasis	4.95e-05	0.000254	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SPP1—nephrolithiasis	4.85e-05	0.000248	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AQP1—nephrolithiasis	4.78e-05	0.000245	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SPP1—nephrolithiasis	4.77e-05	0.000245	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SPP1—nephrolithiasis	4.59e-05	0.000236	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SPP1—nephrolithiasis	4.53e-05	0.000233	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CHRM3—nephrolithiasis	4.33e-05	0.000222	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SPP1—nephrolithiasis	3.97e-05	0.000204	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AQP1—nephrolithiasis	3.69e-05	0.000189	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SPP1—nephrolithiasis	3.52e-05	0.00018	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	3.34e-05	0.000171	CbGpPWpGaD
